icon-    folder.gif   Conference Reports for NATAP  
 
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
 
 
 
Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested US clinical samples: 2006 to 2012
 
 
  Reported by Jules Levin
CROI 2013
 
Erkki Lathouwers,1 Chrispin Kambili,2 Mojgan Haddad,3 Agnes Paquet,3 Sandra De Meyer,1 Bryan Baugh4
1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Janssen Global Services, Titusville, NJ, USA; 3Monogram Biosciences, South San Francisco, CA, USA; 4Janssen Therapeutics, Titusville, NJ, USA

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif

CROI8.gif